Offsets deal reached to fund US FDA, NIH 'Cures' bill

This article was originally published in SRA

21 May 2015
News

Donna Young @ScripDonnaDC Donna.young@informa.com

Executive Summary

Republican and Democratic leaders of the US House energy and commerce committee late on 20 May said they had reached a deal on how they will pay for the expected $13bn costs of implementing the provisions in the proposed 21st Century Cures Act (HR 6). The bill is aimed at overhauling the US biomedical enterprise, and is intended to speed up the discovery, development and approval processes for therapies, devices and diagnostics¹.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS118232

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS118232

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Offsets deal reached to fund US FDA, NIH 'Cures' bill

News

Executive Summary

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert